THOUSAND OAKS, Calif., Sept.
4, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present
at Citi's 15th Annual Virtual BioPharma Conference at 2:25 p.m. ET
on Thursday, Sept. 10, 2020.
Murdo Gordon, executive vice
president of Global Commercial Operations at Amgen and Peter H. Griffith, executive vice president and
chief financial officer, will present at the conference. Live audio
of the presentation can be accessed from the Events Calendar on
Amgen's website, www.amgen.com, under Investors. A replay of the
webcast will also be available on Amgen's website for at least 90
days following the event.
About Amgen
Amgen is committed to
unlocking the potential of biology for patients suffering from
serious illnesses by discovering, developing, manufacturing and
delivering innovative human therapeutics. This approach begins by
using tools like advanced human genetics to unravel the
complexities of disease and understand the fundamentals of human
biology.
Amgen focuses on areas of high unmet medical need and leverages
its expertise to strive for solutions that improve health outcomes
and dramatically improve people's lives. A biotechnology pioneer
since 1980, Amgen has grown to be one of the world's leading
independent biotechnology companies, has reached millions of
patients around the world and is developing a pipeline of medicines
with breakaway potential.
For more information, visit www.amgen.com and follow
us on www.twitter.com/amgen.
CONTACT: Amgen, Thousand Oaks
Megan Fox, 805-447-1423 (media)
Trish Rowland,
805-447-5631(media)
Arvind Sood, 805-447-1060
(investors)
View original content to download
multimedia:http://www.prnewswire.com/news-releases/amgen-to-present-at-the-15th-annual-citi-biopharma-conference-301124644.html
SOURCE Amgen